Becker's Healthcare August 16, 2024
Recently, U.S cancer screening costs hit $43.2 billion annually. Screening colonoscopies accounted for $23.7 billion, or 55%, of that cost. All other colorectal cancer screening methods, such as stool and blood tests, accounted for only $3.8 billion.
This recent data, alongside the development of non-invasive CRC screenings such as Cologuard and fecal immunochemical testing, have raised questions as to what the future of colonoscopies and CRC screenings may look like.
Three physicians shared their perspectives on the future of colonoscopies with Becker’s.
Editor’s note: Responses have been lightly edited for clarity and length.
Tim Sowerby, MD. Gastroenterologist at MarinHealth Medical Center (Greenbrae, Calif.): Almost all colon cancers develop from benign polyps (adenoma). Removing adenoma prevents the...
Today's Sponsors
Today's Sponsor